Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Pasko

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Safety|November 6, 2008
The epidemiology of drug-induced disorders: the kidneyStephanie S Taber, Deborah A Pasko
Pediatric Nephrology (Berlin, Germany)|October 3, 2003
Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytesDeborah A Pasko, Theresa A Mottes, Bruce A Mueller
Blood Purification|November 25, 2006
Daptomycin clearance during modeled continuous renal replacement therapyMariann D Churchwell, Deborah A Pasko, Bruce A Mueller
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Ofloxacin clearance during continuous hemofiltrationBruce A Mueller, Deborah A Pasko, Kevin M Sowinski
Artificial Organs|August 28, 2003
Higher renal replacement therapy dose delivery influences on drug therapyBruce A Mueller, Deborah A Pasko, Kevin M Sowinski
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2008
Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysisMariann D Churchwell, Deborah A Pasko, William E Smoyer, et al.
Blood Purification|March 5, 2011
Longitudinal hemodiafilter performance in modeled continuous renal replacement therapyDeborah A Pasko, Mariann D Churchwell, Noha N Salama, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 26, 2005
Hyperosmolar solutions in continuous renal replacement therapy for hyperosmolar acute renal failure: a preliminary reportKevin D McBryde, Timothy E Bunchman, Timothy L Kudelka, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2007
Trace element removal during in vitro and in vivo continuous haemodialysisMariann D Churchwell, Deborah A Pasko, Imad F Btaiche, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 16, 2004
In vitro clearance of trace elements via continuous renal replacement therapyAudrey T Nakamura, Imad F Btaiche, Deborah A Pasko, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Safety|November 6, 2008
The epidemiology of drug-induced disorders: the kidneyStephanie S Taber, Deborah A Pasko
Pediatric Nephrology (Berlin, Germany)|October 3, 2003
Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytesDeborah A Pasko, Theresa A Mottes, Bruce A Mueller
Blood Purification|November 25, 2006
Daptomycin clearance during modeled continuous renal replacement therapyMariann D Churchwell, Deborah A Pasko, Bruce A Mueller
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Ofloxacin clearance during continuous hemofiltrationBruce A Mueller, Deborah A Pasko, Kevin M Sowinski
Artificial Organs|August 28, 2003
Higher renal replacement therapy dose delivery influences on drug therapyBruce A Mueller, Deborah A Pasko, Kevin M Sowinski
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2008
Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysisMariann D Churchwell, Deborah A Pasko, William E Smoyer, et al.
Blood Purification|March 5, 2011
Longitudinal hemodiafilter performance in modeled continuous renal replacement therapyDeborah A Pasko, Mariann D Churchwell, Noha N Salama, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 26, 2005
Hyperosmolar solutions in continuous renal replacement therapy for hyperosmolar acute renal failure: a preliminary reportKevin D McBryde, Timothy E Bunchman, Timothy L Kudelka, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2007
Trace element removal during in vitro and in vivo continuous haemodialysisMariann D Churchwell, Deborah A Pasko, Imad F Btaiche, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 16, 2004
In vitro clearance of trace elements via continuous renal replacement therapyAudrey T Nakamura, Imad F Btaiche, Deborah A Pasko, et al.
Pageof 2